Skip to content

Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect

New Tools for the Detection of Micro and NanoPLastics (MNPLs) in Greenhouse Workers as a Population Highly Exposed to Plastics: Effect on Different Biomarkers of Genotoxic Effect

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05910489
Enrollment
25
Registered
2023-06-18
Start date
2024-09-30
Completion date
2025-04-30
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genotoxic Damage, Inflammation, Microplastics, Nanoplastics

Keywords

MNPLs; greenhouse workers

Brief summary

MNPLs effects on human health are still preliminary. Workers exposed to plastic residues are exposed constantly to MNPLs. One of these jobs corresponds to greenhouse workers, that could be considered as a population highly exposed to plastics. The objective of the research is to be able to detect MNPLs on body fluids as well as their potential genotoxic and immunological damage.

Detailed description

The exponential increase in the production/use of plastic translates into a parallel increase of environmental plastic waste that is continuously degraded into MNPLs. Information on the MNPLs' effects on human health is still preliminary and, furthermore, the limitations in current methodologies prevent accurate exposure/risk assessment. This observational study will obtain body samples of greenhouse workers and from a control group. That would allow optimizing specific biomarkers of human MNPLs exposure and the characterization of biomarkers of early effect that allows an association among the exposure to MNPLs and effects on human health.

Interventions

OTHERBiomonitoring of MNPLs in biological samples of greenhouse workers and controls

Detection of biomarkers of exposure and genotoxic effect in biological blood, urine, exhalated air condensate, and feces

Sponsors

Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
CollaboratorOTHER
Hospital Universitario Virgen de la Arrixaca
CollaboratorOTHER
Ricard Marcos
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

of workers exposed to plastic residues: * Working in an operating greenhouse for a period of 1 month or more * Age over 18 years old * Absence of chronic pathology including neoplasia * Absence of infectious disease at the date of sample collection and for a period of more than 2 weeks * Spanish residence Inclusion Criteria of controls : * Age over 18 years old. Matched by age, gender, and lifestyle to the exposed group. * Absence of chronic pathology including neoplasia * Absence of infectious disease at the date of sample collection and for a period of more than 2 weeks * Spanish residence

Exclusion criteria

of workers exposed to plastic residues: * Participation in another clinical study * Pregnancy * Unsigned informed consent

Design outcomes

Primary

MeasureTime frameDescription
Biomonitoring study to detect the presence of MNPLs in body fluidsUp to 1 yearBlood, buccal cells, exhalate breath condensate, feaces and urine will be collected from donors to check for the presence of micro and nanoplastics and/or derivatives
Genotoxicity effects of exposure to MNPLsUp to 1 yearBlood and buccal cells will be collected from donors to check for the presence genotoxic permanent damage, assessed by the micronucleus assay
Study of the effects of MNPLs on immune systemUp to 1 yearBlood will be collected from donors to check if the presence of micro and nanoplastics have an effect on th function of the immune system (signalling and activation) in vivo and in high-risk individuals

Secondary

MeasureTime frameDescription
Surrogate biomarkers after MNPLs exposureUp to 1 yearIf it is possible to correlate the presence of micro and nanoplastics with the presence of plastic derivatives in body fluids, as blood or urine, this will facilitate the detection of plastic, because tecniques to detect surrogate biomarkers as e.g. plasticizers or antioxidants are cheaper and most use than the tecnology to detect MNPLs. For that different analytical tecniques will be used.

Contacts

Primary ContactRicard Marcos
ricard.marcos@uab.cat+34 93 586 20 52

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026